The current valuation score of Uniqure NV is 8.24, ranking 156 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.19, which is -95.16% below the recent high of -0.64 and -37.14% above the recent low of -18.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.